$11.5B
$-150M
(-1.3%)

DE
· Age 76
Source of wealth: Pharmaceuticals
Industry: healthcare
Residence: Tegernsee, DE
{
"bio": [
"Andreas Struengmann and twin brother Thomas were early backers of BioNTech, which partnered with Pfizer to make a vaccine for Covid-19.",
"The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion.",
"The brothers invest in biotech, pharma, life sciences and healthcare companies through their Zug, Switzerland-based investment firm, Santo Holding.",
"In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann."
],
"about": [
"After studying medicine in Freiburg, Germany, Andreas worked as a doctor in South Africa."
]
}